Cardiff Oncology, Inc. (CRDF)
0.998
+0.12
(+13.40%)
USD |
NASDAQ |
Aug 24, 16:00
0.9968
0.00 (0.00%)
After-Hours: 20:00
Cardiff Oncology Debt to Equity Ratio : 0.0172 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0172 |
| March 31, 2026 | 0.0186 |
| December 31, 2025 | 0.0183 |
| September 30, 2025 | 0.0207 |
| June 30, 2025 | 0.0202 |
| March 31, 2025 | 0.0191 |
| December 31, 2024 | 0.0184 |
| September 30, 2024 | 0.0341 |
| June 30, 2024 | 0.0352 |
| March 31, 2024 | 0.0328 |
| December 31, 2023 | 0.0308 |
| September 30, 2023 | 0.0295 |
| June 30, 2023 | 0.0281 |
| March 31, 2023 | 0.0267 |
| December 31, 2022 | 0.0255 |
| September 30, 2022 | 0.0252 |
| June 30, 2022 | 0.0247 |
| March 31, 2022 | 0.0239 |
| December 31, 2021 | 0.0222 |
| September 30, 2021 | 0.0246 |
| June 30, 2021 | 0.0029 |
| March 31, 2021 | 0.0052 |
| December 31, 2020 | 0.0067 |
| September 30, 2020 | 0.0416 |
| June 30, 2020 | 0.0661 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.2475 |
| December 31, 2019 | 0.2084 |
| September 30, 2019 | 0.2895 |
| June 30, 2019 | 0.24 |
| March 31, 2019 | 0.2392 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.2511 |
| December 31, 2017 | 0.2047 |
| September 30, 2017 | 0.3772 |
| June 30, 2017 | 0.4684 |
| March 31, 2017 | 1.552 |
| December 31, 2016 | 0.8365 |
| September 30, 2016 | 0.6124 |
| June 30, 2016 | 0.466 |
| March 31, 2016 | 0.3942 |
| December 31, 2015 | 0.3382 |
| September 30, 2015 | 0.2783 |
| June 30, 2015 | 0.839 |
| March 31, 2015 | 0.6398 |
| December 31, 2014 | 1.791 |
| September 30, 2014 | 1.192 |
| June 30, 2014 | 0.8484 |
| March 31, 2014 | 0.0268 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Ocugen, Inc. | -5.314 |
| CytomX Therapeutics, Inc. | 0.0189 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 37.33M |
| Total Liabilities (Quarterly) | 10.80M |
| Shareholders Equity (Quarterly) | 26.53M |
| Current Ratio | 3.296 |
| Net Debt Paydown Yield | 0.20% |